Table 2.
Association Between miR-499a-5p Expression and Clinicopathological Characteristics of Patients With NSCLC Patients.
| Clinicopathological characteristics | Cases (n) | miR-499a-5p | P value | |
|---|---|---|---|---|
| Low (n, %) | High (n, %) | |||
| Age (years) | 0.695 | |||
| < 55 | 42 | 22 (20.0) | 20 (18.2) | |
| ≥ 55 | 68 | 33 (30.0) | 35 (31.8) | |
| Gender | 0.177 | |||
| Male | 63 | 28 (25.5) | 35 (31.8) | |
| Female | 47 | 27 (24.5) | 20 (18.2) | |
| Tumor size (cm) | < 0.001 | |||
| < 3 | 76 | 29 (26.4) | 47 (42.7) | |
| ≥ 3 | 34 | 26 (23.6) | 8 (7.3) | |
| Differentiation | 0.056 | |||
| Well/moderate | 50 | 20 (18.2) | 30 (27.3) | |
| Poor | 60 | 35 (31.8) | 25 (22.7) | |
| Histological type | 0.305 | |||
| Adenocarcinoma | 29 | 11 (10.0) | 18 (16.4) | |
| Squamous cell carcinoma | 43 | 24 (21.8) | 19 (17.3) | |
| Others | 38 | 20 (18.2) | 18 (16.4) | |
| TNM stage | 0.001 | |||
| I/II | 69 | 26 (23.6) | 43 (39.1) | |
| III | 41 | 29 (26.4) | 12 (10.9) | |
| Lymph node metastasis | 0.101 | |||
| No | 87 | 40 (36.4) | 47 (42.7) | |
| Yes | 23 | 15 (13.6) | 8 (7.3) | |
| Smoking | 0.152 | |||
| No | 75 | 34 (30.9) | 41 (37.3) | |
| Yes | 35 | 21 (19.1) | 14 (12.7) | |